MarketScreener Homepage > Equities > Hong Kong Stock Exchange > WuXi Biologics (Cayman) Inc. 2269 KYG970081090

Report

End-of-day quote Hong Kong Stock Exchange - 01/21
114.4	HKD		-1.89%

01/05

WUXI BIOLOGICS (CAYMAN) : Major Shareholder Strikes $1.3 Billion Share Placement Deal; Shares Drop 3%

2020

WUXI BIOLOGICS CAYMAN : Bayer sells a facility at its Wuppertal site to WuXi Biologics

2020

WUXI BIOLOGICS CAYMAN : Germany Unit Acquires Manufacturing Facility from Bayer

Summary

Quotes 5-day view End-of-day quote.

End-of-day quote Hong Kong Stock Exchange

01/15/2021	01/18/2021	01/19/2021	01/20/2021	01/21/2021	Date
103	104.6	110.8	116.6	114.4	Last
15394070	8223990	23046950	19108140	17214550	Volume
-1.62%	+1.55%	+5.93%	+5.23%	-1.89%	Change

Financials

Sales 2020	5 403 M 835 M 835 M
Net income 2020	1 482 M 229 M 229 M
Net cash position 2020	4 624 M 715 M 715 M
P/E ratio 2020	264x
Yield 2020	-

Sales 2021	8 064 M 1 246 M 1 246 M
Net income 2021	2 108 M 326 M 326 M
Net cash position 2021	3 842 M 594 M 594 M
P/E ratio 2021	189x
Yield 2021	-

Capitalization	390 B 60 374 M 60 302 M
EV / Sales 2020	71,4x
EV / Sales 2021	47,9x
Nbr of Employees	5 694
Free-Float	-

More Financials

Company

WUXI BIOLOGICS (CAYMAN) INC. is an investment holding company. The Company along with its subsidiaries is mainly engaged in the discovery, research and development, manufacturing and sales of biologics products. The Companyâ€™s primary products include the clinical active pharmaceutical ingredients, sterile liquid preparations, freeze-dried preparations, as well as small molecules antibiotics for injection drugs....

Sector

Calendar

03/22

Earnings Release

More about the company

Notations Surperformance© of WuXi Biologics (Cayman) Inc.

Trading Rating :

Investor Rating :

More Ratings

All news about WUXI BIOLOGICS (CAYMAN) INC.

01/05	WUXI BIOLOGICS (CAYMAN) : Major Shareholder Strikes $1.3 Billion Share Placement..	MT
2020	WUXI BIOLOGICS CAYMAN : Bayer sells a facility at its Wuppertal site to WuXi Bio..	AQ
2020	WUXI BIOLOGICS CAYMAN : Germany Unit Acquires Manufacturing Facility from Bayer	MT
2020	HK stocks end lower as U.S. ban ramps up pressure on China	RE
2020	WUXI BIOLOGICS CAYMAN : AC Immune and WuXi Biologics Strengthen Strategic Partne..	AQ
2020	WUXI BIOLOGICS CAYMAN : AB2 Bio and WuXi Biologics Announce Collaboration to Acc..	AQ
2020	China, Hong Kong stocks rise on strong quarterly earnings, financials boost	RE
2020	WUXI BIOLOGICS CAYMAN : Shares Soar on Upbeat Revenue Guidance, China's Vaccine ..	DJ
2020	ANTENGENE : Announces Collaboration with WuXi Biologics to Advance the Developme..	PR
2020	WUXI BIOLOGICS CAYMAN : Plans Stock Split	DJ
2020	WUXI BIOLOGICS CAYMAN : Proposed share subdivision	PU
2020	Hong Kong shares slump as possible SMIC blacklisting sinks tech names	RE
2020	WUXI BIOLOGICS (CAYMAN) INC. : half-yearly earnings release
2020	WUXI BIOLOGICS (CAYMAN) INC. : Press Release	CO
2020	WUXI BIOLOGICS (CAYMAN) INC. : Half-year results	CO

More news

News in other languages on WUXI BIOLOGICS (CAYMAN) INC.

2020	WUXI BIOLOGICS (CAYMAN) INC. : publication des résultats semestriels
2020	WUXI BIOLOGICS (CAYMAN) INC. : Veröffentlichung des Halbjahresergebnisses

More news

Analyst Recommendations on WUXI BIOLOGICS (CAYMAN) INC.

2020

WUXI BIOLOGICS CAYMAN : Shares Soar on Upbeat Revenue Guidance, China's Vaccine ..

More recommendations

Provided by Scoopnest.com

Analysis

Alibaba, Xiaomi to join Hong Kong's Hang Seng Index